Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013

Wed Jan 23, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130123:nPnLA46637


UNION CITY, Calif.,  Jan. 23, 2013  /PRNewswire/ -- Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood analysis
systems, has scheduled a conference call to discuss its financial results for
the third quarter of fiscal year 2013, ended  December 31, 2012. The call will
be at  4:15 p.m. ET  on  Thursday, January 31, 2013.  The Company will report
financial results for the third quarter of fiscal 2013 after the market closes
on  Thursday, January 31, 2013.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference
call, or can listen via a live Internet web cast, which is available in the
Investor Relations section of the Company's website at  www.abaxis.com. A replay
of the call is available by visiting  www.abaxis.com  for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code 10024107, through 
February 7, 2013.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems
for use in any veterinary or human patient-care setting to provide clinicians
with rapid blood constituent measurements.  The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required to perform a
panel of up to 13 tests on veterinary patients and 14 tests on human patients. 
The system can be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples.  The system provides test results
in less than 12 minutes with the precision and accuracy equivalent to a clinical
laboratory analyzer.  The veterinary business also provides to the animal health
and research market a line of hematology instruments for point-of-care complete
blood counts (CBC), a specialty instrument to screen for and detect clotting
disorders and to measure equine fibrinogen levels, a handheld instrument for the
rapid assessment of certain critical care tests and rapid point-of-care tests
for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through
its AVRL division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.

 Contact:  Clint Severson           Lytham Partners, LLC                
           Chief Executive Officer  Joe Dorame, Joe Diaz & Robert Blum  
           Abaxis, Inc.             602-889-9700                        
           510-675-6500                                                 


SOURCE  Abaxis, Inc.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.